Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder Asena...
Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
About this item
Full title
Author / Creator
Publisher
Dove Medical Press
Journal title
Language
English
Formats
Publication information
Publisher
Dove Medical Press
More information
Scope and Contents
Contents
Delia Bishara1, David Taylor1,21Pharmacy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London, UK; 2Division of Pharmaceutical Sciences, King’s College, London, UKAbstract: Asenapine is a new atypical antipsychotic agent currently under development for the treatment of schizophrenia and bipolar disorder. It has hig...
Alternative Titles
Full title
Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a505025bb6854ca5b5e8c41bb5f7597a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a505025bb6854ca5b5e8c41bb5f7597a
Other Identifiers
ISSN
1176-6328
E-ISSN
1178-2021
